Jon Marc Wigginton Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jon Marc Wigginton.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jon Marc Wigginton. Jon Marc Wigginton is Senior VP, Clinical Dev. in MACROGENICS INC ($MGNX) and Sr VP Clinical Dev & CMO in MACROGENICS INC ($MGNX) and Sr VP, Clinical in MACROGENICS INC ($MGNX) and Sr VP, Clinical Dev & CMO in MACROGENICS INC ($MGNX) and Sr VP, Clinical Dev. & CMO in MACROGENICS INC ($MGNX) and Director in SUTRO BIOPHARMA, INC. ($STRO) and Chief Medical Officer in Cullinan Management, Inc. ($CGEM).
Latest Insider Trading Transactions of Jon Marc Wigginton
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CGEM, MGNX, STRO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 11 2021 | CGEM | Cullinan Managemen ... | Wigginton Jon Marc | Chief Medical Offic ... | Option Exercise | A | 21.00 | 116,666 | 2,449,986 | 116,666 | |
| Dec 01 2020 | STRO | SUTRO BIOPHARMA, I ... | Wigginton Jon Marc | Director | Option Exercise | A | 17.10 | 24,000 | 410,400 | 24,000 | |
| Feb 24 2020 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Option Exercise | A | 11.50 | 100,000 | 1,150,000 | 100,000 | |
| Feb 24 2020 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Option Exercise | A | 11.50 | 100,000 | 1,150,000 | 100,000 | |
| Feb 25 2019 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Option Exercise | A | 21.88 | 90,000 | 1,969,200 | 90,000 | |
| Mar 06 2018 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Option Exercise | A | 28.94 | 70,000 | 2,025,800 | 70,000 | |
| Jan 18 2018 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Option Exercise | M | 4.70 | 2,524 | 11,863 | 45,448 | |
| Jan 18 2018 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Option Exercise | M | 4.70 | 2,476 | 11,637 | 47,972 | |
| Jan 18 2018 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Sell | S | 20.00 | 2,524 | 50,480 | 30,000 | 32.5 K to 30 K (-7.76 %) |
| Jan 18 2018 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Buy | M | 4.70 | 2,524 | 11,863 | 32,524 | 30 K to 32.5 K (+8.41 %) |
| Jan 18 2018 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Sell | S | 20.00 | 2,476 | 49,520 | 30,000 | 32.5 K to 30 K (-7.62 %) |
| Jan 18 2018 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Buy | M | 4.70 | 2,476 | 11,637 | 32,476 | 30 K to 32.5 K (+8.25 %) |
| Nov 21 2017 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Option Exercise | M | 4.70 | 5,000 | 23,500 | 50,448 | |
| Nov 21 2017 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Sell | S | 20.00 | 5,000 | 100,000 | 30,000 | 35 K to 30 K (-14.29 %) |
| Nov 21 2017 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Buy | M | 4.70 | 5,000 | 23,500 | 35,000 | 30 K to 35 K (+16.67 %) |
| Oct 26 2017 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Option Exercise | M | 4.70 | 10,000 | 47,000 | 55,448 | |
| Oct 26 2017 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Sell | S | 20.00 | 10,000 | 200,000 | 30,000 | 40 K to 30 K (-25.00 %) |
| Oct 26 2017 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Buy | M | 4.70 | 10,000 | 47,000 | 40,000 | 30 K to 40 K (+33.33 %) |
| Jun 06 2017 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Option Exercise | M | 4.70 | 5,000 | 23,500 | 65,448 | |
| Jun 06 2017 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Sell | S | 20.00 | 5,000 | 100,000 | 30,000 | 35 K to 30 K (-14.29 %) |
| Jun 06 2017 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Buy | M | 4.70 | 5,000 | 23,500 | 35,000 | 30 K to 35 K (+16.67 %) |
| Apr 20 2017 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Option Exercise | M | 4.70 | 15,000 | 70,500 | 70,448 | |
| Apr 20 2017 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Sell | S | 20.00 | 15,000 | 300,000 | 30,000 | 45 K to 30 K (-33.33 %) |
| Apr 20 2017 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Buy | M | 4.70 | 15,000 | 70,500 | 45,000 | 30 K to 45 K (+50.00 %) |
| Feb 16 2017 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Option Exercise | A | 20.53 | 67,500 | 1,385,775 | 67,500 | |
| Oct 05 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Option Exercise | M | 4.70 | 10,000 | 47,000 | 15,254 | |
| Oct 05 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Sell | S | 29.34 | 10,000 | 293,400 | 0 | 10 K to 0 (-100.00 %) |
| Oct 05 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Buy | M | 4.70 | 10,000 | 47,000 | 10,000 | 0 to 10 K |
| Aug 03 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP Clinical Dev ... | Option Exercise | M | 4.70 | 20,000 | 94,000 | 35,254 | |
| Aug 03 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP Clinical Dev ... | Option Exercise | M | 4.70 | 20,000 | 94,000 | 35,254 | |
| Aug 03 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP Clinical Dev ... | Option Exercise | M | 4.70 | 20,000 | 94,000 | 35,254 | |
| Aug 03 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP Clinical Dev ... | Sell | S | 30.78 | 20,000 | 615,600 | 0 | 20 K to 0 (-100.00 %) |
| Aug 03 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP Clinical Dev ... | Sell | S | 30.78 | 20,000 | 615,600 | 0 | 20 K to 0 (-100.00 %) |
| Aug 03 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP Clinical Dev ... | Sell | S | 30.78 | 20,000 | 615,600 | 0 | 20 K to 0 (-100.00 %) |
| Aug 03 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP Clinical Dev ... | Buy | M | 4.70 | 20,000 | 94,000 | 20,000 | 0 to 20 K |
| Aug 03 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP Clinical Dev ... | Buy | M | 4.70 | 20,000 | 94,000 | 20,000 | 0 to 20 K |
| Aug 03 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP Clinical Dev ... | Buy | M | 4.70 | 20,000 | 94,000 | 20,000 | 0 to 20 K |
| Jul 06 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP Clinical Dev ... | Option Exercise | M | 4.70 | 5,000 | 23,500 | 55,254 | |
| Jul 06 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP Clinical Dev ... | Sell | S | 27.22 | 5,000 | 136,100 | 0 | 5 K to 0 (-100.00 %) |
| Jul 06 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP Clinical Dev ... | Buy | M | 4.70 | 5,000 | 23,500 | 5,000 | 0 to 5 K |
| Feb 29 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Grant | A | 0.00 | 30,000 | 0 | 30,000 | 0 to 30 K |
| Jan 06 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Option Exercise | M | 4.70 | 10,000 | 47,000 | 60,254 | |
| Jan 06 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Sell | S | 29.64 | 10,000 | 296,400 | 0 | 10 K to 0 (-100.00 %) |
| Jan 06 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Buy | M | 4.70 | 10,000 | 47,000 | 10,000 | 0 to 10 K |
| Dec 22 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Option Exercise | A | 31.43 | 55,000 | 1,728,650 | 55,000 | |
| Oct 02 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Option Exercise | M | 4.70 | 5,000 | 23,500 | 45,194 | |
| Oct 02 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Sell | S | 21.11 | 5,000 | 105,550 | 0 | 5 K to 0 (-100.00 %) |
| Oct 02 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Buy | M | 4.70 | 5,000 | 23,500 | 5,000 | 0 to 5 K |
| Aug 03 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Option Exercise | M | 4.70 | 10,000 | 47,000 | 50,194 | |
| Aug 03 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Sell | S | 37.15 | 10,000 | 371,500 | 0 | 10 K to 0 (-100.00 %) |
| Aug 03 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Buy | M | 4.70 | 10,000 | 47,000 | 10,000 | 0 to 10 K |
| Jul 01 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Option Exercise | M | 4.70 | 5,000 | 23,500 | 60,194 | |
| Jul 01 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Sell | S | 37.15 | 5,000 | 185,750 | 0 | 5 K to 0 (-100.00 %) |
| Jul 01 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Buy | M | 4.70 | 5,000 | 23,500 | 5,000 | 0 to 5 K |
| Apr 03 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Option Exercise | M | 4.70 | 5,000 | 23,500 | 65,194 | |
| Apr 03 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Sell | S | 30.86 | 5,000 | 154,300 | 0 | 5 K to 0 (-100.00 %) |
| Apr 03 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Buy | M | 4.70 | 5,000 | 23,500 | 5,000 | 0 to 5 K |
| Aug 19 2014 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Senior VP, Clinical ... | Option Exercise | M | 4.70 | 5,000 | 23,500 | 80,194 | |
| Aug 19 2014 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Senior VP, Clinical ... | Sell | S | 20.52 | 5,000 | 102,600 | 0 | 5 K to 0 (-100.00 %) |
| Aug 19 2014 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Senior VP, Clinical ... | Buy | M | 4.70 | 5,000 | 23,500 | 5,000 | 0 to 5 K |
Page: 1